Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1996
08/20/1996US5547940 Using a polypeptide
08/20/1996US5547932 Transfection
08/20/1996US5547856 Hepatocyte growth factor variants
08/20/1996US5547854 DNA encoding a receptor for Mullerian inhibitory substance, misr1, and corresponding vectors, cells, probes, and recombinant methods
08/20/1996US5547748 Carbon nanoencapsulates
08/20/1996US5547696 Growth hormone stabilized with valine
08/20/1996US5547682 Reticulendothelial system contrast agent for use in magnetic resonance imaging
08/20/1996US5547680 Sterilizing carboxypolymethylene solution having acidic ph by heating, forming aminocaproic acid by combining it with water, sterilizating by filter sterilization, combining both solutions to form gel, prevents secondary hemorrhage
08/20/1996US5547668 Conjugates of folate anti-effector cell antibodies
08/20/1996US5547667 Linker for bioactive agents
08/20/1996US5547662 Preparation of a skin surface for a surgical procedure
08/20/1996CA2019324C Fosinopril tablet formulations
08/15/1996WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS
08/15/1996WO1996024618A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
08/15/1996WO1996024598A1 [4-hexadecyl-3-methoxy-butyl] phosphonic acid and its protein conjugates useful as anti-cancer agents
08/15/1996WO1996024378A2 Delivery of exogenous compounds
08/15/1996WO1996024377A1 Medicament in particle form
08/15/1996WO1996024376A1 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid
08/15/1996WO1996024370A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996WO1996024369A1 Formulations for il-12
08/15/1996WO1996024364A2 Antimicrobial composition composed of controlled release glasses
08/15/1996WO1996024359A1 Novel pharmaceutical formulation
08/15/1996WO1996024355A1 Novel pharmaceutical combination
08/15/1996WO1996024354A1 Novel pharmaceutical composition
08/15/1996WO1996024339A1 Compositions comprising nanoparticles of nsaid
08/15/1996WO1996024338A1 New pharmaceutical formulation and process
08/15/1996WO1996024335A1 Sugar base surfactant for nanocrystals
08/15/1996WO1996024331A1 New medical forms with prolonged effect applied in eye medicine and the method for preparation thereof
08/15/1996WO1996012019A3 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
08/15/1996WO1996007397A3 Delivery of solid drug compositions
08/15/1996CA2212682A1 Delivery of exogenous compounds
08/15/1996CA2212520A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996CA2212054A1 Gnrh-leukotoxin chimeras
08/15/1996CA2212041A1 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid
08/15/1996CA2211464A1 Novel pharmaceutical composition
08/15/1996CA2211409A1 Novel pharmaceutical formulation
08/15/1996CA2210664A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
08/15/1996CA2206430A1 Sugar base surfactant for nanocrystals
08/14/1996EP0726075A1 Pharmaceutical non-inorganic saline solutions for endonasal administration
08/14/1996EP0725832A1 Transfection process
08/14/1996EP0725823A1 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA)
08/14/1996EP0725656A1 Cell control and suppression
08/14/1996EP0725648A1 Hepatoselective pharmaceutical actives
08/14/1996EP0725642A1 Stabilized prostaglandin e 1?
08/14/1996EP0725639A1 A stable pharmaceutical composition of terfenadine and ibuprofen
08/14/1996EP0725637A1 Parenteral busulfan for treatment of malignant disease
08/14/1996EP0725634A1 Plaster for the treatment of nail mycoses
08/14/1996EP0725630A1 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
08/14/1996EP0725628A1 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
08/14/1996EP0725626A1 Gelatin capsule fill able to foam
08/14/1996EP0646003B1 Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres
08/14/1996EP0615443B1 Immediate-effect flurbiprofen-containing medicament and its use
08/14/1996EP0474714B1 A fructose-based granulated product and a process for the production thereof
08/14/1996EP0471751B1 Antineoplastic solution and method for treating neoplasms
08/14/1996CN1128955A Percutaneously absorbable prepn.
08/14/1996CN1128671A Cyclosporin soft capsule composition
08/14/1996CN1128655A Injectable liposomal pharmaceutical prepn.
08/13/1996US5545727 DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
08/13/1996US5545722 Hepatocyte-growth agent
08/13/1996US5545721 Reacting crosslinker derivatized antibiotic with crosslinker derivatized immunoglobulin to form conjugate which bonds to surface of microorganisms
08/13/1996US5545632 Administering inositol triphosphate isomer to human or mammal to prevent or treat aids
08/13/1996US5545628 Pharmaceutical composition containing fenofibrate
08/13/1996US5545626 Decrease intraocular pressure
08/13/1996US5545413 Dosage form for administering oral hypoglycemic glipizide
08/13/1996US5545412 Using lipophilic compounds to transfect dna and for drug delivery by forming complexes to penetrate cellular membranes
08/08/1996WO1996023882A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
08/08/1996WO1996023817A1 Method of preparing low-viscosity cationic biopolymers
08/08/1996WO1996023794A1 High molecular weight polymer-based prodrugs
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023510A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
08/08/1996WO1996023507A1 Sucralfate preparation
08/08/1996WO1996023500A1 New stable ganelic formulations containing an acid-labile benzimidazol compound, and production process
08/08/1996WO1996023498A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
08/08/1996WO1996023493A1 New pharmaceutical composition containing trimebutine and preparation process
08/08/1996WO1996023479A2 Anti-adhesive active principles
08/08/1996WO1996023463A1 Transdermal formulation
08/08/1996WO1996016661A3 Use of prostaglandin e1, e2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents
08/08/1996WO1996015816A3 Stable n-terminally linked dtpa:protein compositions and methods
08/08/1996WO1996013610A3 Methods and reagents for the identification and regulation of senescence-related genes
08/08/1996DE19503465A1 Verfahren zur Herstellung von niedrigviskosen kationischen Biopolymeren Process for the preparation of low-viscosity cationic biopolymers,
08/08/1996DE19503423A1 Antiadhäsive Wirkstoffe Anti-adhesive agents
08/08/1996CA2212046A1 Sucralfate preparations
08/08/1996CA2211993A1 Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof
08/08/1996CA2211916A1 New pharmaceutical composition containing trimebutine and preparation process
08/08/1996CA2211586A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection___________________________________________
08/08/1996CA2210711A1 Transdermal formulation
08/07/1996EP0725141A1 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland
08/07/1996EP0725056A1 Perfluoroalkylated derivatives of lysine, process for their preparation, their use especially in cosmetics and compositions containing them
08/07/1996EP0724886A1 Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
08/07/1996EP0724643A1 Endosomolytically active particles
08/07/1996EP0724618A1 Stabilisation of polyunsaturates
08/07/1996EP0724564A1 Use of terminal group capped fatty acid amide alkoxylates
08/07/1996EP0724457A1 Radiation sensitization using texaphyrins
08/07/1996EP0724452A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND $g(a)-TOCOPHEROL
08/07/1996EP0724449A1 Preservative for pharmaceutical products
08/07/1996EP0724441A1 Picosulphate dosage form
08/07/1996EP0724437A1 Anthelmintic formulations
08/07/1996EP0724436A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
08/07/1996EP0724432A1 Methods and compositions for microencapsulation of antigens for use as vaccines
08/07/1996EP0724427A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them
1 ... 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 ... 1712